NCT04556773
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04556773
Title A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer (DB-08)
Acronym DB-08
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | CAN | BRA | BEL | AUS

Facility Status City State Zip Country Details
Research Site Commack New York 11725 United States Details
Research Site Harrison New York 10604 United States Details
Research Site New York New York 10029 United States Details
Research Site New York New York 10065 United States Details
Research Site Uniondale New York 11553 United States Details
Research Site Chapel Hill North Carolina 27514 United States Details
Research Site Chattanooga Tennessee 37404 United States Details
Research Site Germantown Tennessee 38138 United States Details
Research Site Fort Worth Texas 76104 United States Details
Research Site East Melbourne 3002 Australia Details
Research Site Westmead 2145 Australia Details
Research Site Edegem 2650 Belgium Details
Research Site Leuven 3000 Belgium Details
Research Site Ottignies 1340 Belgium Details
Research Site Goiânia 74605-070 Brazil Details
Research Site Porto Alegre 90035-003 Brazil Details
Research Site Porto Alegre 90110-270 Brazil Details
Research Site São Paulo 03102-002 Brazil Details
Research Site São Paulo 04543-000 Brazil Details
Research Site Kelowna British Columbia V1Y 5L3 Canada Details
Research Site Québec Quebec G1J 1Z4 Canada Details
Research Site Villejuif 94805 France Details
Research Site Monterrey 64710 Mexico Details
Research Site Moscow 115478 Russia Details
Research Site Moscow 143442 Russia Details
Research Site Saint Petersburg 199226 Russia Details
Research Site Seoul 03080 South Korea Details
Research Site Seoul 03722 South Korea Details
Research Site Seoul 05505 South Korea Details
Research Site Seoul 06351 South Korea Details
Research Site Kaohsiung City 82445 Taiwan Details
Research Site Taichung 40443 Taiwan Details
Research Site Taipei 100 Taiwan Details
Research Site Taipei 11217 Taiwan Details
Research Site Taipei 114 Taiwan Details
Research Site Taipei 235 Taiwan Details
Research Site Taoyuan District 333 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field